Literature DB >> 24066198

Role of cardiac MRI in the assessment of nonischemic cardiomyopathies.

Mahwash Kassi1, Faisal Nabi.   

Abstract

In this review, we will highlight the role of late gadolinium enhancement, along with other strengths available by cardiac MRI, in determining the underlying etiology of various nonischemic cardiomyopathies. Furthermore, we will also emphasize how late gadolinium enhancement may serve as a novel risk stratification tool to further impact patient care.

Entities:  

Keywords:  CMR; dilated cardiomyopathy; late gadolinium enhancement; left ventricular noncompaction; nonischemic cardiomyopathy

Mesh：

Year:  2013        PMID： 24066198      PMCID： PMC3782322          DOI： 10.14797/mdcj-9-3-149

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN： 1947-6108


  36 in total

1.  Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria.

Authors:  Frank I Marcus; William J McKenna; Duane Sherrill; Cristina Basso; Barbara Bauce; David A Bluemke; Hugh Calkins; Domenico Corrado; Moniek G P J Cox; James P Daubert; Guy Fontaine; Kathleen Gear; Richard Hauer; Andrea Nava; Michael H Picard; Nikos Protonotarios; Jeffrey E Saffitz; Danita M Yoerger Sanborn; Jonathan S Steinberg; Harikrishna Tandri; Gaetano Thiene; Jeffrey A Towbin; Adalena Tsatsopoulou; Thomas Wichter; Wojciech Zareba
Journal:  Eur Heart J       Date:  2010-02-19       Impact factor: 29.983

2.  Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy.

Authors:  Carsten Rickers; Norbert M Wilke; Michael Jerosch-Herold; Susan A Casey; Prasad Panse; Neeta Panse; Jochen Weil; Andrey G Zenovich; Barry J Maron
Journal:  Circulation       Date:  2005-08-09       Impact factor: 29.690

3.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

4.  Cardiovascular magnetic resonance in cardiac amyloidosis.

Authors:  Alicia Maria Maceira; Jayshree Joshi; Sanjay Kumar Prasad; James Charles Moon; Enrica Perugini; Idris Harding; Mary Noelle Sheppard; Philip Alexander Poole-Wilson; Philip Nigel Hawkins; Dudley John Pennell
Journal:  Circulation       Date:  2005-01-03       Impact factor: 29.690

5.  Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.

Authors:  Imran S Syed; James F Glockner; Dali Feng; Philip A Araoz; Matthew W Martinez; William D Edwards; Morie A Gertz; Angela Dispenzieri; Jae K Oh; Diego Bellavia; A Jamil Tajik; Martha Grogan
Journal:  JACC Cardiovasc Imaging       Date:  2010-02

6.  Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy.

Authors:  G M Felker; R E Thompson; J M Hare; R H Hruban; D E Clemetson; D L Howard; K L Baughman; E K Kasper
Journal:  N Engl J Med       Date:  2000-04-13       Impact factor: 91.245

7.  Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging.

Authors:  Harikrishna Tandri; Manoj Saranathan; E Rene Rodriguez; Claudia Martinez; Chandra Bomma; Khurram Nasir; Boas Rosen; João A C Lima; Hugh Calkins; David A Bluemke
Journal:  J Am Coll Cardiol       Date:  2005-01-04       Impact factor: 24.094

8.  Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy.

Authors:  Oliver Bruder; Anja Wagner; Christoph J Jensen; Steffen Schneider; Peter Ong; Eva-Maria Kispert; Kai Nassenstein; Thomas Schlosser; Georg V Sabin; Udo Sechtem; Heiko Mahrholdt
Journal:  J Am Coll Cardiol       Date:  2010-06-25       Impact factor: 24.094

9.  Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy.

Authors:  Ankur Gulati; Andrew Jabbour; Tevfik F Ismail; Kaushik Guha; Jahanzaib Khwaja; Sadaf Raza; Kishen Morarji; Tristan D H Brown; Nizar A Ismail; Marc R Dweck; Elisa Di Pietro; Michael Roughton; Ricardo Wage; Yousef Daryani; Rory O'Hanlon; Mary N Sheppard; Francisco Alpendurada; Alexander R Lyon; Stuart A Cook; Martin R Cowie; Ravi G Assomull; Dudley J Pennell; Sanjay K Prasad
Journal:  JAMA       Date:  2013-03-06       Impact factor: 56.272

Review 10.  Role of cardiovascular magnetic resonance imaging in arrhythmogenic right ventricular dysplasia.

Authors:  Aditya Jain; Harikrishna Tandri; Hugh Calkins; David A Bluemke
Journal:  J Cardiovasc Magn Reson       Date:  2008-06-20       Impact factor: 5.364
View more
  3 in total

1.  Detecting cardiac involvement with magnetic resonance in patients with active eosinophilic granulomatosis with polyangiitis.

Authors:  Sehyo Yune; Dong-Chull Choi; Byung-Jae Lee; Jin-Young Lee; Eun-Seok Jeon; Sung Mok Kim; Yeon Hyeon Choe
Journal:  Int J Cardiovasc Imaging       Date:  2016-02-01       Impact factor: 2.357

2.  Magnetic Resonance Imaging of Non-ischemic Cardiomyopathies: A Pictorial Essay.

Authors:  Cristina I Olivas-Chacon; Carola Mullins; Kevan Stewart; Nassim Akle; Jesus E Calleros; Luis R Ramos-Duran
Journal:  J Clin Imaging Sci       Date:  2015-06-30

3.  Prognostic value of late gadolinium enhancement in cardiac MRI of non-ischemic dilated cardiomyopathy patients.

Authors:  Dibya Ranjan Behera; Ajit Kumar V K; Narayanan Namboodiri K K; Sivasankaran S; Krishna Kumar Mohanan Nair; Sanjay G; Kapilamoorthy T R; Arun Gopalakrishnan; Harikrishnan S
Journal:  Indian Heart J       Date:  2020-07-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.